Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston
Biotech
British biotech CellCentric expands to Boston, plans hiring push
The U.S. hub will lead accelerated approval and phase 3 studies for multiple myeloma asset inobrodib.
Darren Incorvaia
Apr 2, 2025 1:53pm
Roche to house its CVRM research work at new Boston hub
Mar 7, 2025 9:40am
GSK to move vaccine R&D group from Maryland to Massachusetts
Feb 12, 2025 11:27am
Novo taps Photys for multi-molecule cardiometabolic collab
Dec 18, 2024 7:30am
Eli Lilly opens $700M nucleic acid R&D center in Boston Seaport
Aug 13, 2024 9:32am
Novo Nordisk unveils new US hub as R&D investments soar
Feb 29, 2024 5:00am
